We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Quotient Clinical Announces ADME Success in Oncology

News   Apr 02, 2015

 
Quotient Clinical Announces ADME Success in Oncology
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Existing Drugs Could Stop SARS-CoV-2 From Hijacking Cells

News

A team has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The scientists have also identified seven existing drugs that could disrupt these mechanisms.

READ MORE

Combination Therapy Improves Survival Rates for Women With Aggressive Endometrial Cancer in Phase 2 Trial

News

Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE